HISTOPLASMOSIS IN NON-HIV IMMUNOCOMPROMISED PATIENT RESIDING IN A NON-ENDEMIC AREA IN BRAZIL
DOI:
10.46551/ruc.v23n2a05Keywords:
Histoplasmosis, Histoplasma capsulatum, ImmunocompromisedAbstract
Introduction: Histoplasmosis is a fungal disease, caused by Histoplasma capsulatum. Goal: To report a case of an immunocompromised patient with diagnosis of histoplasmosis in a non-endemic region. Methodology: Case report. Case report: Patient carrier of rheumatoid arthritis, makes continuous use of methotrexate and has reported contact with large amount of bat guano. Result of cervical lymph node culture was positive for H. capsulatum. Discussion: The infection was presented related to drug-induced immunosuppression in a non-endemic area. Conclusion: In view of the location where the infection occurred, the geographic expansion of the disease and the importance of this report for the literature are clear.
Downloads
References
Teixeira MDM, Patané JSL, Taylor ML, Gómez BL. Worldwide Phylogenetic Distributions and Population Dynamics of the Genus Histoplasma. PLoS Negl Trop Dis. 2016;1–20.
Brown EM, McTaggart LR, Dunn D, Pszczolko E, Tsui KG, Morris SK, et al. Epidemiology and geographic distribution of blastomycosis, histoplasmosis, and coccidioidomycosis, Ontario, Canada, 1990–2015. Emerg Infect Dis. 2018;24(7):1257–66.
Silva TC, Treméa CM, Zara ALSA, Mendonça AF, Godoy CSM, Costa CR, et al. Prevalence and lethality among patients with histoplasmosis and AIDS in the Midwest Region of Brazil. Mycoses. 2017;60(1):59–65.
Faiolla RCL, Coelho MC, Santana R de C, Martinez R. Histoplasmosis in immunocompetent individuals living in an endemic area in the Brazilian Southeast. Rev Soc Bras Med Trop. 2013;46(4):461–5.
Muniz M de M. Caracterização Molecular do Histoplasma capsulatum isolados no Brasil. 2009.
Passos AN, Kohara VS, Freitas RS De, Vicentini AP, Paulo S, Médica LDM, et al. Immunological assays employed for the elucidation of an histoplasmosis outbreak in São Paulo , SP. Brazilian J Microbiol. 2014;1361(4):1357–61.
Unimontes Científica, Montes Claros (MG), Brasil, v. 23, n. 2, p. 1-9, jul./dez. 2021.
Garfoot AL, Rappleye CA, State O. Histoplasma capsulatum surmounts obstacles to intracellular pathogenesis. FEBS J. 2017;283(4):619–33.
Hage CA, Azar MM, Bahr N, Loyd J, Wheat LJ. Histoplasmosis: Up-to-Date Evidence-Based Approach to Diagnosis and Management. Semin Respir Crit Care Med. 2015;36(5):729–45.
Nair U, Moorthy RS, Cunningham ET. Histoplasmosis. Intraocular Inflamm. 2016;30:1293–9.
Guimarães AJ, Nosanchuk JD, Zancopé-Oliveira RM. Diagnosis of histoplasmosis. Brazilian J Microbiol. 2006;37(1):1–13.
Scheel CM, Gómez BL. Diagnostic Methods for Histoplasmosis: Focus on Endemic Countries with Variable Infrastructure Levels. Curr Trop Med Reports. 2014;1(2):129–37.
Libert D, Procop GW, Ansari MQ. Histoplasma Urinary Antigen Testing Obviates the Need for Coincident Serum Antigen Testing. Am J Clin Pathol. 2018;149:362-368.
Sanford. Sanford Guide. 2019.
Fernandes CTC. Impactos Socioambientais de Grandes Barragens e Desenvolvimento : a percepção dos atores locais sobre a Usina Hidrelétrica de Serra da Mesa. 2010.
Singer-Leshinsky S. Pulmonary tuberculosis. J Am Acad Physician Assist [Internet]. 2016;29(2):20–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26757063%0Ahttp://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=01720610-201602000-00003
Press D. Leishmaniasis in humans : drug or vaccine therapy ? Drug Des Dev Ther. 2018;25–40.
Unimontes Científica, Montes Claros (MG), Brasil, v. 23, n. 2, p. 1-9, jul./dez. 2021
Migiyama Y, Yanagihara K, Kaku N, Harada Y, Yamada K, Nagaoka K, et al. Pseudomonas aeruginosa bacteremia among immunocompetent and immunocompromised patients: Relation to initialantibiotic therapy and survival. Jpn J Infect Dis. 2016;69(2):91–6.
